
Marina Udier
executiveFemale0.0Global Dominance: 0.00%
Marina Udier is the Chief Executive Officer of Nouscom, where she is dedicated to transforming cancer treatment through innovative therapies. Under her leadership, the company is advancing the NOUS-209 vaccine, aiming to redefine the role of immunotherapy in oncology, particularly for those with Lynch syndrome.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Marina Udier is the CEO of Nouscom who committed to further developing the NOUS-209 vaccine.
Vacuna para prevenir el cáncer demuestra eficacia en un ensayo clínicoListín Diario – oldest Dominican newspaper, est. 1889·
Dominican Republic· 2026-01-17

